Rentabilitas dodolan miturut bathi resik Intensity Tx (INTS)

Tandha merek Intensity Therapeutics Inc (INTS)

Intensity Therapeutics' strategy of attracting leading oncologists ensures the development of unique therapy methods. Net income per unit of sales in the historical data on the GURU.Markets chart demonstrates cost management efficiency, where the 0.00 indicator expresses the state of the metric. This is supported by the pricing power of the DIGNIT platform and the business's high resilience to macroeconomic fluctuations due to the specifics of medical demand.

INTS: Rentabilitas resik perusahaan intensitytherapeutics.com 21.02.2024 - 19.11.2026

Rincian analitis perusahaan Intensity Therapeutics

Ringkesan analitik perusahaan:Intensity Tx - INTS
Barang unggulan intensitytherapeutics.com

The indicator is calculated as the ratio of net income to total revenue, reflecting the final efficiency of operating activities. This metric measures the portion of every dollar earned that remains after covering all expenses and taxes. For Intensity Therapeutics (INTS), this balance is determined by the costs of laboratory sterility and chemical disposal. An analysis of sales returns based on net income reveals the actual resilience of the business. The dynamics of this curve serve as a signal for a shift in the profitability trend.

Analisis pesaing

NantKwest (IBRX) - Margin resik|Margin resik Immunocore PLC (IMCR)|Rentabilitas dodolan miturut bathi resik JANX|RCUS - Tingkat bathi miturut bathi resik|Rentabilitas dodolan miturut bathi resik ZYME (Zymeworks Corp)|Rentabilitas resik perusahaan TNGX|Margin dodolan resik IOVA (Iovance Biotherapeutics, Inc.)|Tingkat bathi resik IMTX|xencor.com - Margin dodolan resik|Margin resik Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Margin resik|Lyell Immunopharma - Tingkat bathi resik|IPHA (innate-pharma.com) - Margin dodolan resik|Margin dodolan resik pyxisoncology.com|Margin resik cgen.com (CGEN)|IOBT: Margin bathi resik|Sutro Biopharma Inc. - Rentabilitas dodolan miturut bathi resik|minktherapeutics.com (INKT) - Margin resik|HOWL: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Immix Biopharma IMMX|ALX Oncology (ALXO) - Margin resik|Margin resik Cue Biopharma, Inc. (CUE)|Margin resik PDS Biotechnology Corporation|Rentabilitas dodolan resik SONN (sonnetbio.com)|Margin dodolan resik MAIA|Margin dodolan perusahaan Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Rentabilitas dodolan miturut bathi resik|NXTC - Rentabilitas dodolan miturut bathi resik|LPTX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Sensei Biotherapeutics Inc SNSE|TOVX: Margin dodolan resik|Margin resik Gritstone Bio (GRTS)|KA (Kineta Corp) - Margin dodolan resik|Rentabilitas dodolan resik NEXI (NexImmune Corp)|Margin dodolan resik TSBX|VCNX (Vaccinex, Inc.) - Tingkat bathi resik|Margin dodolan resik HARP (Harpoon Therapeutics, Inc.)